CME 7018 Share Price
| PREV | CLOSE | CHANGE | HIGH | CLOSE |
|---|---|---|---|---|
| 0.055 | - | - | - | - |
| VOLUME | BUY VOL | BUY | SELL | SELL VOL |
|---|---|---|---|---|
| - | 168,764 | 0.050 | 0.055 | 23,982 |
52 Weeks Range : 0.02 - 0.16
2.8/10
(Expert Score)
Product is rated as #221 in category BM Industrial Products & Services
PROS:
- Very High Trading Value
CONS:
- Poor Income Near Future
- No Dividend Declared
- Very Low Price-to-Tangible
- High Debt Company
- Very High Gearing
- Face Stock Dillution
klse: CME Group Bhd
Corporate Information
Board : Main
Shariah : Shariah Compliant
Sector : Industrial Products Ringgit
Address: Lot 19, Jalan Delima 1/1, Subang Hi-Tech Industrial Park, Shah Alam, 40000, Selangor
Contact: +603-56331188
Website: https://www.cme.com.my/
Corporate Background
CME Group Berhad is an investment holding company. Through its subsidiaries, the Company sells, services, and manufactures fire fighting equipment, fire engines and related spare parts.
Specification: CME 7018
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 30/11/20 | 1,704 | -147 | -147 |
| 28/08/20 | 1,268 | -1,517 | -2,235 |
| 30/06/20 | 10,323 | 723 | 723 |
| 28/02/20 | 16,673 | 2,968 | 2,968 |
| 29/11/19 | 909 | 353 | -1,279 |
| 29/08/19 | 24,442 | -19,817 | -19,727 |
| 28/05/19 | 4,107 | -1,388 | -1,388 |
| 28/02/19 | 4,368 | -1,142 | -1,142 |
| 27/11/18 | 4,840 | -1,434 | -1,434 |
| 30/08/18 | 4,791 | -8,864 | -9,168 |
| 30/05/18 | 10,253 | -574 | -574 |
| 26/02/18 | 3,117 | -1,047 | -1,047 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 29,968 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | 1,309 |
| Last 4 Quarter EPS (sen) | 0.23 |
| Last 4 Quarter PER | 36.98 |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | – |
| Net Tangible Assets (RM) | 0.06 |
| Goodwill (RM) | 0 |
| Cash (RM’000) | 5,970 |
| Debt (RM’000) | 56,500 |
| Total Debt (RM’000) | 84,820 |
| Net Assets (RM’000) | 5,630 |
| Current Ratio | 0.36 |
| Quick Ratio | 0.22 |
| Cash Ratio | 0.12 |
Technical
Technical Analysis
| MACD (26 vs 12) | – |
|---|---|
| Exponential Moving Average 5 | 0.056 |
| Exponential Moving Average 20 | 0.054 |
| Exponential Moving Average 90 | 0.059 |
| Relative Strength Index 14 | 0.56 |
| Stochastic %D 3 | 0.67 |
| Stochastic %K 14 | 0.50 |
5 reviews for CME 7018
Show all
Most Helpful
Highest Rating
Lowest Rating
Add a review
| PREV | CLOSE | CHANGE | HIGH | CLOSE |
|---|---|---|---|---|
| 0.055 | - | - | - | - |
| VOLUME | BUY VOL | BUY | SELL | SELL VOL |
|---|---|---|---|---|
| - | 168,764 | 0.050 | 0.055 | 23,982 |
REMUNERATION STUDY –
In Financial Year End 2020, the directors’ remuneration was 0.34 million. It was slightly low compared to average in listed companies, considering the employees’ remuneration of 2.4 million and auditor’s remuneration of 94 thousands
New Straits Times –
Bioalpha Holdings Bhd (BHB) through its wholly-owned subsidiary Bioalpha International Sdn Bhd (BISB) inked a collaborative agreement with CME Health Sdn Bhd (CME Health), a wholly-owned subsidiary of CME Group Bhd (CGB) to develop, manufacture and supply health food supplements to market in Southeast Asia. Under the agreement, BISB shall become CME Health’s product development partner and the exclusive sole manufacturer of the immune health food supplement products. CME Health is also granted the exclusive rights to market, sell, promote and distribute these products in the SEA region.
BURSA MALAYSIA –
The Group registered a total revenue of RM1.3 million, a decrease of RM9.1 million or 87.7% as compared to the preceding quarter ended 31 March 2020. The Group recorded a loss before tax of RM1.5 million for the current quarter as compared to profit before tax of RM0.7 million in the preceding quarter. The decrease was mainly due to lower revenue recorded.
BURSA MALAYSIA –
The Group registered a revenue of RM10.3 million, a decrease of RM6.3 million or 38.1% as compared to the preceding quarter. The Group recorded a profit before tax of RM0.7 million for the current quarter as compared to RM2.9 million in the preceding quarter. The decrease mainly due to lower revenue.
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 0.46 million. It was slightly low compared to average in listed companies, considering the employees’ remuneration of 3.3 million and auditor’s remuneration of 149 thousands
Investing Malaysia –
Average investing volume for CME Group Bhd in the past three months in stock market was 284k lots
Investing Malaysia –
CME gets a score of 7.57 in our equity and assets quality test based on current share price of RM0.035
Investing Malaysia –
CME Group Bhd gets a score of 0 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 7018 in Bursa Malaysia did not propose any dividend for the past few years
Investing Malaysia –
CME is forecasted to made loss of 2.66 millions, with an adjusted market capitalization of 43.15 millions